Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study

An increased risk of developing severe infections has been evidenced in rheumatic disease (RD) patients, and anti-COVID-19 vaccination is strictly recommended for RD patients. However, up to now, no data are available on safety, immunogenicity and efficacy of COVID-19 vaccinations in RD patients. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotondo, Cinzia, Cantatore, Francesco Paolo, Fornaro, Marco, Colia, Ripalta, Busto, Giuseppe, Rella, Valeria, Sciacca, Stefania, Lops, Lucia, Cici, Daniela, Maruotti, Nicola, D’Onofrio, Francesca, Iannone, Florenzo, Corrado, Addolorata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310114/
https://www.ncbi.nlm.nih.gov/pubmed/34358147
http://dx.doi.org/10.3390/vaccines9070730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310114/
https://www.ncbi.nlm.nih.gov/pubmed/34358147
http://dx.doi.org/10.3390/vaccines9070730

Ejemplares similares